FDA 510(k) Search - By Innolitics (SaMD and AI Experts)

An enzyme linked immunosorbant assay (ELISA) for the semi-quantitative detection of IgG autoantibodies to serine protease 3 (PR3). This test is to be used in conjunction with other clinical findings to aid in the assessment of certain autoimmune vasculitides such as Wegener's granulomatosis.

Device Description

An enzyme linked immunosorbant assay (ELISA) for the semi-quantitative detection of IgG autoantibodies to serine protease 3 (PR3).

AI/ML Overview

The provided text is a 510(k) clearance letter from the FDA for a device called "QUANTA Lite™ PR3 IgG". This letter approves the marketing of the device, but it does not contain the acceptance criteria or the study details proving the device meets those criteria.

The letter primarily states that the device is "substantially equivalent" to previously marketed devices and outlines regulatory information for the manufacturer. It specifies the "Indications For Use" which describe what the device is intended for, but not how well it performs.

Therefore, I cannot provide the requested information from this document. The document refers to a "510(k) premarket notification" which would contain the study data and acceptance criteria, but that is not included here.

Ask a Question

Ask a specific question about this device

K Number

K955021

Device Name

QUANTA LITE PR3

Manufacturer

INOVA DIAGNOSTICS, INC.

Date Cleared

1996-03-19

(138 days)

Product Code